Skip to main content
search

Vaidya Sane Ayurved Laboratories Ltd (Madhavbaug) NSE SME-IPO Prospectus

Thank You All!

Vaidya Sane Ayurved Laboratories Ltd (Madhavbaug) gets NSE approval for SME IPO

 

It has long been my dream to transform the health of our great nation with the wisdom of Ayurveda and continued clinical research.

This journey began 16 years ago, when I ventured into the field of Ayurvedic medicine, using my knowledge of modern medicine & Ayurveda to address the growing trend of non-communicable diseases, such as heart disease and diabetes that continue to afflict India.

This vision of reversing non-communicable diseases could never have been realized without your constant support that has been a source of strength and encouragement. From our humble beginnings, with the inauguration of the first Madhavbaug Hospital back in 2006, we have grown to have a presence of 2 hospitals and 274 clinics across the country.

Your support, the dedication of our team of over 450 doctors and 600 Plus person staff and the continued patronage of over 3 lakh patients each year has helped us break boundaries and redefine the care of non-communicable diseases. However, my vision of a healthier India that is free from non-communicable diseases is far from complete. Today, thanks to your support we are a step closer to realizing this vision as we are set to launch our SME IPO in Feb 2022.

This announcement is humbling to say the least and the achievement would have been impossible without your support and research into the science of Ayurveda. So, I would like to thank each one of you for making my dream a reality. With your continued support, we can further the reach of Ayurveda to transform the future of healthcare in India

With gratitude,
Dr. Rohit Sane
Founder & CEO, Madhavbaug

 

Vaidya Sane Ayurved Laboratories Ltd (Madhavbaug)
NSE (Emerge) SME-IPO
Issue opens on: Thursday, 10 Feb 2022

SymbolMADHAVBAUG
SeriesEQ
Issue PeriodFebruary 10, 2022 to February 15, 2022
Post issue Modification PeriodFebruary 16, 2022 (10.00 A.M. to 11.00 A.M.)
Cut-off time for UPI Mandate ConfirmationFebruary 16, 2022 (up to 12:00 PM)
Issue SizeInitial Public Issue of upto 27,71,200 equity shares (Including market maker portion of 1,40,800 equity shares)
Issue TypeFixed Price
Issue PriceRs.73 ( Including Premium of Rs 63)
Face ValueRs 10
Tick SizeRe.1
Market Lot1600 Equity Shares and in multiples thereof
Minimum Order Quantity1600 Equity Shares
Maximum Subscription Amount for Retail InvestorRs.200000
IPO Market Timings10.00 a.m. to 5.00 p.m.
Lead ManagerFirst Overseas Capital limited
Sponsor BankAxis Bank Limited
Self Certified Syndicate Banks (SCSBs) eligible as Issuer Banks for UPIIssuer Banks for UPI
CategoriesFI, IC, MF, FII, OTH, CO, IND and NOH
Name of the RegistrarBigshare Services Private Limited
Address of the Registrar1st floor, Bharat Tin Works Building, Opp. Vasant Oasis, Makwana Road,Marol, Andheri (East), Mumbai- 400 059, Maharashtra, India.
Contact person name, number and Email idAshish Bhope , + 91 22 6263 8200; ipo@bigshareonline.com
e-form linke-Forms
Branches of Self Certified Syndicate Banks (SCSBs) where syndicate / sub syndicate member to submit ASBA formSCSB List
ProspectusClick Here
Sample Application FormsClick Here
Live ParametersClick Here
List of mobile applications accepting UPI as Payment OptionMobile APP for UPI
Video link for UPI based ASBA processUPI Based ASBA Process
Video link for BHIM UPI RegistrationBHIM UPI Registration

For more information regarding
Vaidya Sane Ayurved Laboratories Ltd (Madhavbaug)
NSE (Emerge) SME-IPO

 

Download Prospectus PDF Link:  https://www1.nseindia.com/emerge/corporates/content/Vaidya_Sane_Prosp.pdf

Visit NSE Website to Know More: https://www1.nseindia.com/emerge/live_market/content/live_watch/ipo/sme_ipo.htm

 

CONTACT PERSON
Abhishek Deshpande, Company Secretary & Compliance Officer

Phone: +91 7738070019
E-mail: cs@madhavbaug.com

*As per SEBI circular no SEBI/HO/CFD/DIL2/CIR/P/2019/76 dated June 28,2019, all Syndicate Members / Registered Stock Brokers / DPs / RTAs shall use Unified Payments Interface (UPI) as a mandatory payment mechanism for bid amounting to Rs. 2 Lakhs and below for applications in public issues by retail individual investors and Share Holders. *All Other Category of investors shall mandatorily use only Application Supported by Blocked Amount (ASBA) facility for making payments.

1 to 1 Discussion with CA Rachana Ranade & Dr Rohit Sane on Madhavbaug NSE SME IPO

Disclaimer: Vaidya Sane Ayurved Laboratories Limited proposes, subject to market conditions, public issue of its Equity Shares and has filed the Prospectus with the ROC, NSE and SEBI. The Prospectus is available on the website of NSE www.nseindia.com/emerge/ and the website of the Lead Manager at www.focl.in. Investors should note that investment in Equity Shares involves a high degree of risk. For details investors should refer to and rely on the Prospectus including the section titled “Risk Factors” beginning on Page 19 of the Prospectus, which has been filed with Registrar of Companies (ROC) .

Close Menu

Share page on WhatsApp

Enter your Name and WhatsApp Mobile Number below to share current page information on your or Relatives WhatsApp Number.





    Share page on WhatsApp

    Enter your Name and WhatsApp Mobile Number below to share current page information on your or Relatives WhatsApp Number.





      X
      Share page on WhatsApp